Rick Larsen
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
4 flagsRep. Larsen bought $1K-$15K in $GOOGL on Jan 7, 2025 — 30 days before the Growing and Preserving Innovation in America Act (HR1062) was introduced, which locks in higher tax deductions for US multinationals and would directly benefit Alphabet's foreign IP income.
Rep. Larsen bought $1K-$15K in $GOOGL on Jan 7, 2025 — 62 days before the American Innovation and R&D Competitiveness Act (HR1990) was introduced, which would restore immediate R&D expensing and lower Alphabet's effective tax rate.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $GOOGL | Alphabet Inc. - Class A Common Stock (GOOGL) [ST] | $1K-$15K | $195.49 | $349.94 | +79.0% | Jan 7, 2025 |
| BUY | $BR | Broadridge Financial Solutions, Inc. Common Stock (BR) [ST] | $1K-$15K | — | — | — | Jan 7, 2025 |
| BUY | $CTAS | Cintas Corporation - Common Stock (CTAS) [ST] | $1K-$15K | $188.72 | — | — | Jan 7, 2025 |
| BUY | $VRSK | Verisk Analytics, Inc. - Common Stock (VRSK) [ST] | $1K-$15K | — | — | — | Jan 7, 2025 |
| SELL | $BAH | Booz Allen Hamilton Holding Corporation Common Stock (BAH) [ST] | $1K-$15K | $129.24 | — | — | Jan 7, 2025 |
| SELL | $CMCSA | Comcast Corporation - Class A Common Stock (CMCSA) [ST] | $1K-$15K | $37.18 | $26.76 | -28.0% | Jan 7, 2025 |
| SELL | $GD | General Dynamics Corporation Common Stock (GD) [ST] | $1K-$15K | $259.65 | — | — | Jan 7, 2025 |
| SELL | $UNH | UnitedHealth Group Incorporated Common Stock (UNH) [ST] | $1K-$15K | — | — | — | Jan 7, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
No Tax Breaks for Outsourcing Act
The No Tax Breaks for Outsourcing Act (S409) would eliminate tax deferral on foreign profits for U.S. multinationals, increasing effective tax rates by 5-8 percentage points. The bill is in early stages (referred to Senate Finance Committee, 19 cosponsors) and poses a 4-8% annual net income headwind for high international-exposure companies. Despite 8-30% rallies in the last 30 days across MSFT, AAPL, GOOGL, KO, PG, XOM, and CVX, this legislative risk is not currently priced into valuations.
American Innovation and R&D Competitiveness Act of 2025
HR1990, the American Innovation and R&D Competitiveness Act, would restore immediate expensing for R&D costs, reversing the 2022 tax code change that required 5/15-year amortization. This is an early-stage bill referred to Ways and Means with 81 cosponsors, but if enacted, it would provide a direct 21% tax-rate cash flow benefit annually to every R&D-intensive US company. The largest absolute beneficiaries are mega-cap tech and pharma firms with $10B+ annual R&D budgets.
Metastatic Breast Cancer Access to Care Act
HR 2048 eliminates the 29-month cumulative waiting period for SSDI and Medicare for metastatic breast cancer patients. The bill is in early legislative stages (referred to Ways and Means), but the identical Senate companion (S3442) increases passage odds. Major health insurers ($UNH, $HUM, $CVS, $CI, $MOH, $CNC) would benefit from accelerated Medicare enrollment, bringing forward premium revenue. Over the past 7 days these tickers have rallied 3.4% to 28.5%, significantly outperforming the broad market, driven in part by sector-wide momentum around Medicare-related legislation.
Growing and Preserving Innovation in America Act of 2025
HR1062 permanently locks in higher FDII and GILTI deductions for US multinationals, preventing a ~3.3 ppt effective tax rate increase on foreign IP income scheduled for 2026. This directly boosts after-tax net income for companies with large international revenue streams, including MSFT, AAPL, GOOGL, AMZN, NVDA, JNJ, PFE, KO, and PG. The bill is in early committee stage — structural impact is contingent on passage through the 119th Congress.
To prohibit the issuance of licenses for the exportation of certain defense articles to the United Arab Emirates, and for other purposes.
HR2059 directly prohibits defense article exports to the UAE until it certifies cessation of support for the Rapid Support Forces in Sudan. This bill blocks multi-billion dollar F-35 (Lockheed), F-15 (Boeing), Patriot (RTX), and armored vehicle (General Dynamics) sales to a top-tier Middle East customer. The defense sector faces a direct revenue headwind, with Lockheed Martin most exposed given its $512 level and 7-day decline of -7.77%.
Digital Integrity in Democracy Act
The Digital Integrity in Democracy Act (S. 840) removes Section 230 immunity for social media platforms hosting false election administration information, directly increasing legal and operational costs for META and GOOGL. The bill is in early legislative stages (referred to committee) with limited momentum (4 cosponsors, no companion), so near-term market impact is moderate but structurally negative. META's current price of $603.33 reflects a 10.62% 7-day decline; GOOGL at $368.85 has rallied 28.27% in 30 days but faces specific YouTube liability risk.
Sustainable Cardiopulmonary Rehabilitation Services in the Home Act
The Sustainable Cardiopulmonary Rehabilitation Services in the Home Act (S.248) permanently codifies COVID-era telehealth flexibilities for Medicare-covered cardiac and pulmonary rehab in patient homes. This expands the addressable market for home health agencies and telehealth providers. Addus HomeCare ($ADUS) is the pure-play beneficiary; UnitedHealth ($UNH) gains through both its MA insurance and Optum home health arms. The bill is early-stage — referred to Senate Finance — requiring committee markup and passage before market impact materializes.
I CAN Act
The I CAN Act (HR1317) structurally lowers healthcare labor costs by expanding APRN scope under Medicare/Medicaid, directly benefiting managed care insurers. Real market data confirms managed-care insurers $CNC (+27.93% 7-day, +63.41% 30-day), $MOH (+10.81% 7-day, +46.26% 30-day), and $HUM (+12.05% 7-day, +39.09% 30-day) are already pricing in this regulatory tailwind. The bill is early-stage but has a companion in the Senate and executive-order tailwinds — pure-play Medicaid/Medicare insurers are the structural winners.
Broadband Grant Tax Treatment Act
The Broadband Grant Tax Treatment Act (HR1873) would exclude BEAD and related broadband grants from federal taxable income, increasing effective grant value for recipients by ~21%. For operators $T, $VZ, $CMCSA, and $LBRDA, this directly improves rural broadband project economics. For equipment suppliers $CIEN and $GLW, it pulls through higher optical and fiber demand. The bill is at early stage (referred to Ways and Means) with a Senate companion. No real price movement attributable to this bill has occurred given its early stage.
To repeal the Impoundment Control Act of 1974.
HR1180, introduced February 2025, would repeal the Impoundment Control Act of 1974. The bill has 25 cosponsors and a Senate companion but sits at early committee stage. Near-term market impact is negligible. If advanced, structural risk to federal contractor cash flow would be material for defense prime contractors Lockheed Martin ($LMT), Northrop Grumman ($NOC), and General Dynamics ($GD). Current market data shows LMT down 15.6% and NOC down 15.47% over 30 days, with GD nearly flat — consistent with broader defense sector headwinds unrelated to this bill.
Other Filings by Rick Larsen
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.